Skip to content
July 22, 2026
  • Trump’s 200% Generic Drug Tariff Plan Puts India’s Pharma Exports in Focus
  • Can Papaya Leaf Boost Platelets? Tata Memorial Study Faces Global Scientific Scrutiny
  • Agilus Diagnostics Appoints Vijender Singh as Managing Director & CEO
  • After Dengue Vaccine Approval, Is India Closer to a Malaria Vaccine?
tishha_logo

Tishha News

  • Home
  • News
  • Economics
  • Technology Innovations
  • Global Healthcare
  • Expert Talks
  • Web Stories
  • Home
  • TruBridge

TruBridge

image 8
  • Merger and Acquisition

IKS Healthcare Eyes $600 Million TruBridge Acquisition to Expand US Presence

tishha_newsApril 13, 2026April 13, 202605 mins

Inventurus Knowledge Solutions (IKS Healthcare), backed by the family of late investor Rakesh Jhunjhunwala, is in advanced discussions to acquire…

Read More

Most Viewed

Global Healthcare
Trump’s 200% Generic Drug Tariff Plan Puts India’s Pharma Exports in Focus
US President Donald Trump has announced a phased tariff policy…
Research Studies
Can Papaya Leaf Boost Platelets? Tata Memorial Study Faces Global Scientific Scrutiny
A recent study from Tata Memorial Hospital (TMH) suggesting that…

Random

1

Trump’s 200% Generic Drug Tariff Plan Puts India’s Pharma Exports in Focus

  • Global Healthcare
2

Can Papaya Leaf Boost Platelets? Tata Memorial Study Faces Global Scientific Scrutiny

  • Research Studies
3

Agilus Diagnostics Appoints Vijender Singh as Managing Director & CEO

  • Placements and Movements
4

After Dengue Vaccine Approval, Is India Closer to a Malaria Vaccine?

  • News
5

CK Birla Hospital Promotes Dr. Davy Jindal as Vice President

  • Placements and Movements
6

Maharashtra Reports 48 Covid-19 Cases in 2026; Health Officials Rule Out Fresh Wave

  • News
7

UP Takes Action Against 16 Hospitals Over Ayushman Bharat Scheme Irregularities

  • News
8

Centre, States Review Progress of AB-PMJAY and ABDM, Discuss Next Phase of Implementation

  • News
tishha_logo
TISHHA News Developed By BlazeThemes.